Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP Facebook

WHO: Dilute vincristine in a minibag

From the July 26, 2007 issue

Last week the World Health Organization (WHO) published a drug alert about vincristine following the death of a 21-year-old woman in Hong Kong who received vincristine via the spinal route. WHO noted that there are at least 55 other cases reported worldwide, all of which were preventable. The Organization suggested that administering vincristine in a diluted volume (e.g., 50 mL normal saline) via a minibag would help deter practitioners from administering the drug via a spinal route, which is almost always fatal. The alert also noted that ISMP supports the use of a minibag to deliver vincristine, as does the Safety and Quality Council in Australia. Based on input gathered from international experts and patient safety organizations, WHO concluded that vincristine (and other vinca alkaloids) should only be given IV via a minibag, not a syringe. The alert called upon individual institutions, professional bodies, and policy makers to research, develop, and promote the separation of IV and spinal delivery systems. The gold standard is to create a unique ‘lock and key’ design of needles, syringes, catheters, tubing, and bags so that medications intended for IV administration cannot be administered inadvertently via the spinal route and vice versa. You can view the complete alert if you visit:


Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Newsletter Editions
Acute Care
Long Term Care
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved